⟵ Back to Search Results
BGB-3111-309

Recruiting

A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy

Beigene Study ID info

BGB-3111-309

ClinicalTrials.gov ID info

NCT05707377

EudraCT Number info

2022-501147-32-00

China Drug Trials ID info

CTR20230546

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents